Living-Donor Liver Transplantation for Erythropoietic Protoporphyria: A Case Report and Literature Review.

Autor: Ogasawara H; Department of Surgery, Tohoku University Graduate School of Medicine., Tokodai K; Department of Surgery, Tohoku University Graduate School of Medicine., Nakanishi W; Department of Surgery, Tohoku University Graduate School of Medicine., Fujio A; Department of Surgery, Tohoku University Graduate School of Medicine., Kashiwadate T; Department of Surgery, Tohoku University Graduate School of Medicine., Shono Y; Department of Surgery, Tohoku University Graduate School of Medicine., Ohta M; Department of Surgery, Tohoku University Graduate School of Medicine., Ishikawa Y; Department of Surgery, Tohoku University Graduate School of Medicine., Miyagi S; Department of Surgery, Tohoku University Graduate School of Medicine., Fujishima F; Department of Pathology, Tohoku University Hospital., Unno M; Department of Surgery, Tohoku University Graduate School of Medicine., Kamei T; Department of Surgery, Tohoku University Graduate School of Medicine.
Jazyk: angličtina
Zdroj: The Tohoku journal of experimental medicine [Tohoku J Exp Med] 2023 Oct 07; Vol. 261 (2), pp. 117-122. Date of Electronic Publication: 2023 Jul 27.
DOI: 10.1620/tjem.2023.J061
Abstrakt: Erythropoietic protoporphyria (EPP) is a very rare disease with an estimated prevalence of 1 in 200,000 individuals. Decreased ferrochelatase activity causes the accumulation of protoporphyrin in the body, and light exposure results in the generation of active oxygen, causing photosensitivity. Liver damage has the greatest influence on the prognosis, and liver transplantation is the only treatment option for patients with decompensated liver cirrhosis. We report a case of living-donor liver transplantation for decompensated liver cirrhosis associated with EPP. The patient was a 52-year-old male who led a normal life except for mild photosensitivity. When the patient was 37-year-old, hepatic dysfunction was noticed. At 48-year-old, high erythrocyte protoporphyrin levels, skin biopsy, and genetic tests resulted in a diagnosis of EPP. The patient underwent living- donor liver transplantation because of decompensated liver cirrhosis. In the operating room and intensive care unit, a special light-shielding film was applied to all light sources to block light with harmful wavelengths during treatment. Due to the need for special measures, a lecture on patients with EPP was given before surgery to deepen understanding among all medical professionals involved in the treatment. As a result, no adverse events occurred during the perioperative period, and the patient was discharged on the 46th post-operative day. Currently, the transplanted liver is functioning extremely well, and the patient is alive 3 years post-transplant. Herein, we describe a case of living donor liver transplantation for EPP with a brief literature review.
Databáze: MEDLINE